Odontoprev SA
BOVESPA:ODPV3

Watchlist Manager
Odontoprev SA Logo
Odontoprev SA
BOVESPA:ODPV3
Watchlist
Price: 13.89 BRL 1.31%
Market Cap: R$7.7B

Odontoprev SA
Investor Relations

OdontoPrev SA engages in the provision of dental and oral health solutions. The company is headquartered in Barueri, Sao Paulo. The company went IPO on 2006-12-01. The firm is involved in the management, sale and provision of private dental care plans and services. The company offers services to individual and corporate customers. The firm organizes its dental care services into three main segments: Collective Pre-paid Plans, Collective Post-paid Plans and Individual Pre-paid Plans. Through its indirect subsidiary Easy Software Ltda, the Company is also active in the development of computer software for the dental industry. Odontoprev SA holds shares in various direct subsidiaries, such as Clidec - Clinica Dentaria Especializada Cura Dar's Ltda, Odontoprev Servicos Ltda, Garcia Pedrosa Ltda and Adcon Administradora de Convenios Odontologicos Ltd. Furthermore, It is a subsidiary of Bradesco Saude SA, a unit of Banco Bradesco SA's Bradesco Seguros e Previdencia SA.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q4 2025
Call Date
Feb 27, 2026
AI Summary
Q4 2025

Revenue Growth: Odontoprev closed the year with first line (revenue) growth of 5.3%, highlighted by strong SME segment expansion under the Bradesco Dental brand.

Record Client Additions: The company achieved a record of 193,000 new lives added during the year, with more than 100,000 coming in the second half; total SME growth across all brands reached 215,000 lives.

Cost Efficiency: Odontoprev reported its most efficient dental care ratio in history at 38.4% for 2024 and 38.9% in 2025, supporting EBITDA margin expansion.

Margin Improvement: EBITDA margin increased from 30.6% in 2024 to 31% in 2025.

Strong Cash Generation: The company generated BRL 562 million in cash flow and ended the year with BRL 713 million in cash after paying BRL 413 million in dividends and interest on capital.

Strategic Integration: Management highlighted the creation of a new health ecosystem with its controller and Bradesco, describing it as a major milestone for future growth.

Pricing & Competition: Management stated that Odontoprev retains a pricing premium versus peers and that ticket (pricing) dynamics differ across segments, with SME volume growth driving revenue while ticket remains stable or slightly up.

Key Financials
EBITDA Margin
31%
Dental Care Ratio
38.9%
Cash Flow
BRL 562 million
Cash Position
BRL 713 million
Dividends and JCP Paid
BRL 413 million
New Lives Added (SME, Bradesco Dental)
193,000
New Lives Added (SME, All Brands)
215,000
Other Earnings Calls

Management

Mr. Elsen Carvalho
CEO & Commercial Director
No Bio Available
Mr. José Roberto Borges Pacheco
Investor Relations Officer & CFO
No Bio Available
Mr. André Chidichimo de França
Legal, Compliance Officer, DPO & Corporate Governance Officer
No Bio Available
Mr. Renato Alves Costa Velloso Dias Cardoso
IT, Marketing & Sustainability Director
No Bio Available
Ms. Rose Gabay
Human Resources Director
No Bio Available
Ms. Stella Hong
IR Supervisor
No Bio Available

Contacts

Address
SAO PAULO
Barueri
Alameda Araguaia, 2104 - 21 Andar, Alphaville
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett